{"denoms":[{"counts":[{"groupId":"BG000","value":"145"}],"units":"Participants"}],"groups":[{"description":"Participants received loncastuximab tesirine as an IV infusion over 30 minutes on Day 1 of each cycle (every 3 weeks) at a dose of 150 μg/kg Q3W for 2 cycles, then 75 μg/kg Q3W for subsequent cycles for up to one year or until disease progression, unacceptable toxicity, or other discontinuation criteria, whichever occurred first.","id":"BG000","title":"Loncastuximab Tesirine"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"13.63","value":"62.7"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"60"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"85"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"13"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"132"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"130"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"5"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"3"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"1"}],"title":"American Indian or Alaskan Native"},{"measurements":[{"groupId":"BG000","value":"1"}],"title":"Native Hawaiian or Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"5"}],"title":"Other"}],"title":"Race"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"59"}]}],"title":"United States"},{"categories":[{"measurements":[{"groupId":"BG000","value":"31"}]}],"title":"United Kingdom"},{"categories":[{"measurements":[{"groupId":"BG000","value":"53"}]}],"title":"Italy"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"Switzerland"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Region of Enrollment","unitOfMeasure":"Participants"}],"populationDescription":"All-treated population - all participants who received at least 1 dose of treatment."}